Actym Therapeutics
Actym Therapeutics is a clinical-stage biotechnology company developing bacterial immunotherapies for solid tumors and fibrotic disease. Its STACT platform engineers an attenuated Salmonella typhimurium vehicle to be administered systemically and to deliver multiple therapeutic payloads that are amplified and produced locally at the disease site, with the goal of raising efficacy while limiting systemic toxicity. Its lead asset, ACTM-838, is in a Phase 1a/1b trial in patients with advanced solid tumors. Actym publishes no developer program, no API and no machine-readable contract; the only agent-facing surfaces on its own domain are a platform-generated llms.txt and an anonymous Wix Site MCP endpoint.
Actym Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Immuno-Oncology.
Actym Therapeutics’ developer surface includes support, authentication, and 11 more developer resources.
Kin Score
MCP Servers 1
Model Context Protocol servers that expose these APIs to AI agents.
Actym Therapeutics Site MCP Server
MCP SERVERPricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Actym Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 2
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.